
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A reservoir of stem-like CD8 + T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response
Kelli A. Connolly, Manik Kuchroo, Aarthi Venkat, et al.
Science Immunology (2021) Vol. 6, Iss. 64
Open Access | Times Cited: 241
Kelli A. Connolly, Manik Kuchroo, Aarthi Venkat, et al.
Science Immunology (2021) Vol. 6, Iss. 64
Open Access | Times Cited: 241
Showing 1-25 of 241 citing articles:
T cells in health and disease
Lina Sun, Yanhong Su, Anjun Jiao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 359
Lina Sun, Yanhong Su, Anjun Jiao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 359
Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses
Can Cui, Jiawei Wang, Eric Fagerberg, et al.
Cell (2021) Vol. 184, Iss. 25, pp. 6101-6118.e13
Open Access | Times Cited: 311
Can Cui, Jiawei Wang, Eric Fagerberg, et al.
Cell (2021) Vol. 184, Iss. 25, pp. 6101-6118.e13
Open Access | Times Cited: 311
The primordial differentiation of tumor-specific memory CD8+ T cells as bona fide responders to PD-1/PD-L1 blockade in draining lymph nodes
Qizhao Huang, Xia Wu, Zhiming Wang, et al.
Cell (2022) Vol. 185, Iss. 22, pp. 4049-4066.e25
Open Access | Times Cited: 248
Qizhao Huang, Xia Wu, Zhiming Wang, et al.
Cell (2022) Vol. 185, Iss. 22, pp. 4049-4066.e25
Open Access | Times Cited: 248
Dynamics and specificities of T cells in cancer immunotherapy
Giacomo Oliveira, Catherine J. Wu
Nature reviews. Cancer (2023) Vol. 23, Iss. 5, pp. 295-316
Closed Access | Times Cited: 240
Giacomo Oliveira, Catherine J. Wu
Nature reviews. Cancer (2023) Vol. 23, Iss. 5, pp. 295-316
Closed Access | Times Cited: 240
Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes
Maha K. Rahim, Trine Line Hauge Okholm, Kyle B. Jones, et al.
Cell (2023) Vol. 186, Iss. 6, pp. 1127-1143.e18
Open Access | Times Cited: 212
Maha K. Rahim, Trine Line Hauge Okholm, Kyle B. Jones, et al.
Cell (2023) Vol. 186, Iss. 6, pp. 1127-1143.e18
Open Access | Times Cited: 212
CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor
Nataliya Prokhnevska, Maria A. Cardenas, Rajesh M. Valanparambil, et al.
Immunity (2022) Vol. 56, Iss. 1, pp. 107-124.e5
Open Access | Times Cited: 193
Nataliya Prokhnevska, Maria A. Cardenas, Rajesh M. Valanparambil, et al.
Immunity (2022) Vol. 56, Iss. 1, pp. 107-124.e5
Open Access | Times Cited: 193
Single-cell meta-analyses reveal responses of tumor-reactive CXCL13+ T cells to immune-checkpoint blockade
Baolin Liu, Yuanyuan Zhang, Dongfang Wang, et al.
Nature Cancer (2022) Vol. 3, Iss. 9, pp. 1123-1136
Closed Access | Times Cited: 172
Baolin Liu, Yuanyuan Zhang, Dongfang Wang, et al.
Nature Cancer (2022) Vol. 3, Iss. 9, pp. 1123-1136
Closed Access | Times Cited: 172
CD8+ T cells in the cancer-immunity cycle
Josephine R. Giles, Anna-Maria Globig, Susan M. Kaech, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2231-2253
Open Access | Times Cited: 161
Josephine R. Giles, Anna-Maria Globig, Susan M. Kaech, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2231-2253
Open Access | Times Cited: 161
‘Stem-like’ precursors are the fount to sustain persistent CD8+ T cell responses
Dietmar Zehn, Robert Thimme, Enrico Lugli, et al.
Nature Immunology (2022) Vol. 23, Iss. 6, pp. 836-847
Open Access | Times Cited: 121
Dietmar Zehn, Robert Thimme, Enrico Lugli, et al.
Nature Immunology (2022) Vol. 23, Iss. 6, pp. 836-847
Open Access | Times Cited: 121
Immune Checkpoint Inhibitors in 10 Years: Contribution of Basic Research and Clinical Application in Cancer Immunotherapy
Jii Bum Lee, Hye Ryun Kim, Sang‐Jun Ha
Immune Network (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 115
Jii Bum Lee, Hye Ryun Kim, Sang‐Jun Ha
Immune Network (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 115
The Abscopal Effect: A Review of Pre-Clinical and Clinical Advances
James Janopaul‐Naylor, Yang Shen, David C. Qian, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11061-11061
Open Access | Times Cited: 106
James Janopaul‐Naylor, Yang Shen, David C. Qian, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11061-11061
Open Access | Times Cited: 106
Targeted modulation of immune cells and tissues using engineered biomaterials
Parisa Yousefpour, Kaiyuan Ni, Darrell J. Irvine
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 2, pp. 107-124
Open Access | Times Cited: 83
Parisa Yousefpour, Kaiyuan Ni, Darrell J. Irvine
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 2, pp. 107-124
Open Access | Times Cited: 83
T cell egress via lymphatic vessels is tuned by antigen encounter and limits tumor control
Maria M. Steele, Abhinav Jaiswal, Ines Delclaux, et al.
Nature Immunology (2023) Vol. 24, Iss. 4, pp. 664-675
Open Access | Times Cited: 80
Maria M. Steele, Abhinav Jaiswal, Ines Delclaux, et al.
Nature Immunology (2023) Vol. 24, Iss. 4, pp. 664-675
Open Access | Times Cited: 80
In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue
Zhi Li, Zewen Kelvin Tuong, Isaac Dean, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 6
Open Access | Times Cited: 77
Zhi Li, Zewen Kelvin Tuong, Isaac Dean, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 6
Open Access | Times Cited: 77
Stem-like exhausted and memory CD8+ T cells in cancer
Thomas Gebhardt, Simone L. Park, Ian A. Parish
Nature reviews. Cancer (2023) Vol. 23, Iss. 11, pp. 780-798
Closed Access | Times Cited: 73
Thomas Gebhardt, Simone L. Park, Ian A. Parish
Nature reviews. Cancer (2023) Vol. 23, Iss. 11, pp. 780-798
Closed Access | Times Cited: 73
Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade
Joy A. Pai, Matthew D. Hellmann, Jennifer L. Sauter, et al.
Cancer Cell (2023) Vol. 41, Iss. 4, pp. 776-790.e7
Open Access | Times Cited: 68
Joy A. Pai, Matthew D. Hellmann, Jennifer L. Sauter, et al.
Cancer Cell (2023) Vol. 41, Iss. 4, pp. 776-790.e7
Open Access | Times Cited: 68
Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma
Mohanraj Ramachandran, Alessandra Vaccaro, Tiarne van de Walle, et al.
Cancer Cell (2023) Vol. 41, Iss. 6, pp. 1134-1151.e10
Open Access | Times Cited: 66
Mohanraj Ramachandran, Alessandra Vaccaro, Tiarne van de Walle, et al.
Cancer Cell (2023) Vol. 41, Iss. 6, pp. 1134-1151.e10
Open Access | Times Cited: 66
Principles and therapeutic applications of adaptive immunity
Hongbo Chi, Marion Pepper, Paul G. Thomas
Cell (2024) Vol. 187, Iss. 9, pp. 2052-2078
Open Access | Times Cited: 64
Hongbo Chi, Marion Pepper, Paul G. Thomas
Cell (2024) Vol. 187, Iss. 9, pp. 2052-2078
Open Access | Times Cited: 64
Localization, tissue biology and T cell state — implications for cancer immunotherapy
Jason M. Schenkel, Kristen E. Pauken
Nature reviews. Immunology (2023) Vol. 23, Iss. 12, pp. 807-823
Open Access | Times Cited: 62
Jason M. Schenkel, Kristen E. Pauken
Nature reviews. Immunology (2023) Vol. 23, Iss. 12, pp. 807-823
Open Access | Times Cited: 62
Simultaneous targeting of PD-1 and IL-2Rβγ with radiation therapy inhibits pancreatic cancer growth and metastasis
Miles Piper, Maureen Hoen, Laurel B. Darragh, et al.
Cancer Cell (2023) Vol. 41, Iss. 5, pp. 950-969.e6
Open Access | Times Cited: 48
Miles Piper, Maureen Hoen, Laurel B. Darragh, et al.
Cancer Cell (2023) Vol. 41, Iss. 5, pp. 950-969.e6
Open Access | Times Cited: 48
KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance
Anastasia‐Maria Zavitsanou, Ray Pillai, Hao Yuan, et al.
Cell Reports (2023) Vol. 42, Iss. 11, pp. 113295-113295
Open Access | Times Cited: 47
Anastasia‐Maria Zavitsanou, Ray Pillai, Hao Yuan, et al.
Cell Reports (2023) Vol. 42, Iss. 11, pp. 113295-113295
Open Access | Times Cited: 47
Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer
Lenka Kašíková, Jana Raková, Michal Hensler, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 32
Lenka Kašíková, Jana Raková, Michal Hensler, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 32
Beyond T cell exhaustion: TIM-3 regulation of myeloid cells
Karen O. Dixon, Gonzalo Fernandez Lahore, Vijay K. Kuchroo
Science Immunology (2024) Vol. 9, Iss. 93
Closed Access | Times Cited: 22
Karen O. Dixon, Gonzalo Fernandez Lahore, Vijay K. Kuchroo
Science Immunology (2024) Vol. 9, Iss. 93
Closed Access | Times Cited: 22
The Multifaceted Role of Tissue-Resident Memory T Cells
Susan N. Christo, Simone L. Park, Scott N. Mueller, et al.
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 317-345
Closed Access | Times Cited: 22
Susan N. Christo, Simone L. Park, Scott N. Mueller, et al.
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 317-345
Closed Access | Times Cited: 22
Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach
Miguel López de Rodas, María Villalba, Miguel F. Sanmamed, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access | Times Cited: 5
Miguel López de Rodas, María Villalba, Miguel F. Sanmamed, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access | Times Cited: 5